Agilon Health (NYSE:AGL) Hits New 52-Week High – What’s Next?

Agilon Health, Inc. (NYSE:AGL) hit a new 52-week high on Thursday . The company traded as high as $109.49 and last traded at $102.08, with a volume of 295802 shares. The stock had previously closed at $102.16.

Analyst Upgrades and Downgrades

AGL has been the subject of a number of research analyst reports. JPMorgan Chase & Co. downgraded shares of Agilon Health from a “neutral” rating to an “underweight” rating and set a $21.00 target price for the company. in a research note on Monday, May 4th. Wall Street Zen raised shares of Agilon Health from a “sell” rating to a “hold” rating in a research note on Saturday, May 9th. Barclays raised shares of Agilon Health from an “underweight” rating to an “equal weight” rating and set a $81.00 target price for the company in a research note on Tuesday, May 26th. Robert W. Baird boosted their target price on shares of Agilon Health from $20.00 to $35.00 and gave the stock a “neutral” rating in a research note on Thursday, May 7th. Finally, Jefferies Financial Group raised shares of Agilon Health from a “hold” rating to a “buy” rating and boosted their target price for the stock from $27.50 to $48.00 in a research note on Thursday, May 7th. Five research analysts have rated the stock with a Buy rating, eight have given a Hold rating and two have given a Sell rating to the company. According to data from MarketBeat, Agilon Health currently has a consensus rating of “Hold” and a consensus price target of $58.73.

Agilon Health Stock Performance

The company has a debt-to-equity ratio of 0.08, a current ratio of 1.04 and a quick ratio of 1.04. The firm has a market capitalization of $1.88 billion, a P/E ratio of -5.24 and a beta of 3.02. The stock’s 50 day moving average is $57.17 and its two-hundred day moving average is $30.68.

Agilon Health (NYSE:AGL) last posted its quarterly earnings results on Wednesday, May 6th. The company reported $1.80 earnings per share for the quarter, topping analysts’ consensus estimates of $1.04 by $0.76. The business had revenue of $1.42 billion during the quarter, compared to the consensus estimate of $1.38 billion. Agilon Health had a negative net margin of 6.09% and a negative return on equity of 146.03%. As a group, equities analysts anticipate that Agilon Health, Inc. will post -3.5 earnings per share for the current fiscal year.

Institutional Investors Weigh In On Agilon Health

A number of institutional investors and hedge funds have recently modified their holdings of AGL. Wealthcare Advisory Partners LLC bought a new stake in shares of Agilon Health during the third quarter worth approximately $26,000. LPL Financial LLC raised its stake in shares of Agilon Health by 213.4% during the fourth quarter. LPL Financial LLC now owns 44,055 shares of the company’s stock worth $30,000 after buying an additional 30,000 shares during the last quarter. Krilogy Financial LLC bought a new stake in shares of Agilon Health during the fourth quarter worth approximately $34,000. CIBC Bancorp USA Inc. bought a new stake in shares of Agilon Health during the third quarter worth approximately $34,000. Finally, Merit Financial Group LLC bought a new stake in Agilon Health in the fourth quarter valued at approximately $35,000.

Agilon Health Company Profile

Agilon Health (NYSE: AGL) is a healthcare company that partners with independent primary care physicians to deliver value-based care for Medicare beneficiaries. Through risk-sharing arrangements, Agilon assumes financial responsibility for patient populations, enabling physicians to focus on preventive and proactive health management. The company provides the administrative, clinical and operational infrastructure needed to support comprehensive care delivery.

Agilon’s platform encompasses data analytics, care management, patient engagement tools and population health programs.